Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Webcast

Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024


Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.

The presentation will be webcast live; a link for the webcast can be found on the Edgewise events page and will be accessible for replay following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.

About Edgewise Therapeutics

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company's deep expertise in muscle physiology is driving a new generation of first-in-class therapeutics. Sevasemten is an orally administered skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, currently in Phase 2 clinical development. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram and Threads.


These press releases may also interest you

at 14:15
"I'm a nurse and I thought there should be a way to combine a tracheal tie together with a tracheal sponge or bib," said an inventor, from Tuscaloosa, Ala., "so I invented the TRACHEAL BIBB. My design would secure and protect the tracheal stoma, and...

at 14:15
Prominently featured in The Inner Circle, Brian J. Hudec, DMD is acknowledged as a Pinnacle Lifetime Member for his contributions to the Dentistry field. Dr. Hudec, a compassionate and dedicated dentist, is making a difference in the field of...

at 14:05
Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65...

at 14:01
University labs around the world are catalysts for breakthrough discoveries that improve humanity, but their work can be shrouded in mystery. Inside the Lab, a new video and Q&A series from the University of Chicago, pulls back the curtain for a...

at 13:53
The Bluffs Addiction Campuses has officially expanded its specialized treatment program, Your Six Recovery (Y6R), dedicated to serving veterans and struggling with addiction and mental health disorders. The ribbon-cutting ceremony on May 13...

at 13:45
The American Academy of Orthopaedic Surgeons (AAOS) announced a formal collaboration with Blue Cross and Blue Shield Association (BCBSA) to allow consenting participants' quality outcomes data from the American Joint Replacement Registry (AJRR) to be...



News published on and distributed by: